A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
The Methodist Hospital Research Institute
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Genentech, Inc.
AstraZeneca
MOMA Therapeutics
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
Boehringer Ingelheim
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, Irvine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
Novartis
Seagen Inc.
Seagen Inc.
Vividion Therapeutics, Inc.
Seagen Inc.
Fate Therapeutics
National Institutes of Health Clinical Center (CC)
Coherus Oncology, Inc.
Alterome Therapeutics, Inc.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
AstraZeneca
Zumutor Biologics Inc.
Novartis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hoffmann-La Roche
IDEAYA Biosciences
Second Affiliated Hospital, School of Medicine, Zhejiang University
M.D. Anderson Cancer Center
Erasca, Inc.
ImmVirx Pty Ltd
Novartis